Nitrite-generated NO circumvents dysregulated arginine/NOS signaling to protect against intimal hyperplasia in Sprague-Dawley rats
Open accessThe DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
Vascular disease, a significant cause of morbidity and mortality in the developed world, results from vascular injury. Following vascular injury, damaged or dysfunctional endothelial cells and activated SMCs engage in vasoproliferative remodeling and the formation of flow-limiting intimal hyperplasia (IH). We hypothesized that vascular injury results in decreased bioavailability of NO secondary to dysregulated arginine-dependent NO generation. Furthermore, we postulated that nitrite-dependent NO generation is augmented as an adaptive response to limit vascular injury/proliferation and can be harnessed for its protective effects. Here we report that sodium nitrite (intraperitoneal, inhaled, or oral) limited the development of IH in a rat model of vascular injury. Additionally, nitrite led to the generation of NO in vessels and SMCs, as well as limited SMC proliferation via p21Waf1/Cip1 signaling. These data demonstrate that IH is associated with increased arginase-1 levels, which leads to decreased NO production and bioavailability. Vascular injury also was associated with increased levels of xanthine oxidoreductase (XOR), a known nitrite reductase. Chronic inhibition of XOR and a diet deficient in nitrate/nitrite each exacerbated vascular injury. Moreover, established IH was reversed by dietary supplementation of nitrite. The vasoprotective effects of nitrite were counteracted by inhibition of XOR. These data illustrate the importance of nitrite-generated NO as an endogenous adaptive response and as a pathway that can be harnessed for therapeutic benefit.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Delivered via intravenous, inhaled, or oral routes, nitrite reduces pulmonary and right heart pressures and prevents or reverses characteristic vascular remodeling and right ventricular hypertrophy (RVH) in several animal models of PAH[15,117,143,146–149].”
From Enterosalivary nitrate metabolism and the microbiome: Intersection of microbial metabolism, nitric oxide and diet in cardiac and pulmonary vascular health (2017) · cites this paper as [117]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition, they link low dietary nitrite levels to increased severity of myointimal hyperplasia following vessel injury in mice.”
From Dietary nitrate, nitric oxide, and restenosis (2011) · cites this paper as [11]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In this issue of the JCI, Alef and colleagues provide evidence that in the injured vessel wall, the disruption of the NOS pathway is countered by induction of xanthine oxidoreductase, an enzyme capable of producing NO from nitrite.”
From Dietary nitrate, nitric oxide, and restenosis (2011) · cites this paper as [11]
The cited source says what the claim attributes to it.
In the citing paper
“They also confirmed that vascular injury induced the expression of vascular iNOS.”
From Dietary nitrate, nitric oxide, and restenosis (2011) · cites this paper as [11]
The cited source says what the claim attributes to it.
In the citing paper
“One week after vascular injury, arginase-1 expression and activity were increased in the injured vessel wall.”
From Dietary nitrate, nitric oxide, and restenosis (2011) · cites this paper as [11]
15 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Mechanism of Catecholamine-Induced Proliferation of Vascular Smooth Muscle Cells
Yu, S., Tsai, S.-Y., Guh, J., Ko, F., Teng, C., & Ou, J. T. (1996) · Circulation · doi:10.1161/01.cir.94.3.547 · Cited by 87 · cited 1×
“ously described (55) from male Sprague-Dawley rats (Harlan).”
BackgroundRetractedThe pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630 · cited 1×
“Introduction Vascular disease contributes significantly to morbidity and mortality in the developed world (1).”
BackgroundThe L-Arginine-Nitric Oxide Pathway
Epstein, F. H., Moncada, S., & Higgs, A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292706 · Cited by 6,678
The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics
Lundberg, J. O., Weitzberg, E., & Gladwin, M. T. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2466 · Cited by 2,739 · cited 3×
“Nitrate (NO3) and nitrite (NO2), once thought to be waste products of NO metabolism, are now known to contribute substantially to NO biology by functioning as an endocrine reservoir capable of being reduced to NO within hypoxic, ischemic, or injured tissues (21, 22).”
BackgroundSelf-citationNitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation
Cosby, K., Partovi, K. S., Crawford, J. H., Patel, R. P., Reiter, C. D., Martyr, S., Yang, B. K., Waclawiw, M. A., Zalos, G., Xu, X., et al. (2003) · Nature Medicine · doi:10.1038/nm954 · Cited by 1,807 · cited 1×
“Several studies have reported the cardiovascular effects of nitrate and/or nitrite, including influences on vasodilation and blood pressure (26, 46).”
BackgroundSelf-citationWebb, A. J., Patel, N., Loukogeorgakis, S., Okorie, M., Aboud, Z., Misra, S., Rashid, R., Miall, P., Deanfield, J., Benjamin, N., et al. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.103523 · Cited by 1,078
Berry, C. E., & Hare, J. M. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2003.055913 · Cited by 927 · cited 1×
“XOR is a highly conserved member of the molybdoenzyme family and is best known for its catalytic role in purine degradation, metabolizing hypoxanthine and xanthine to uric acid with associated generation of superoxide (49).”
BackgroundMediterranean diet and incidence of and mortality from coronary heart disease and stroke in women
Fung, T. T., Rexrode, K. M., Mantzoros, C. S., Manson, J. E., Willett, W. C., & Hu, F. B. (2009) · Circulation · doi:10.1161/circulationaha.108.816736 · Cited by 916 · cited 1×
“It is known that the Mediterranean diet is inversely related to vascular disease (47, 48).”
BackgroundEnzyme-independent formation of nitric oxide in biological tissues
Zweier, J. L., Wang, P., Samouilov, A., & Kuppusamy, P. (1995) · Nature Medicine · doi:10.1038/nm0895-804 · Cited by 788
von der Leyen, H. E., Gibbons, G. H., Morishita, R., Lewis, N. P., Zhang, L., Nakajima, M., Kaneda, Y., Cooke, J. P., & Dzau, V. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.4.1137 · Cited by 762 · cited 1×
“NO has been shown to have many vasoprotective properties, which has led to investigation into NO-based therapies to prevent vaso-occlusive complications of vascular injury (44, 45).”
BackgroundDuncan, C., Dougall, H., Johnston, P., Green, S., Brogan, R., Leifert, C., Smith, L., Golden, M., & Benjamin, N. (1995) · Nature Medicine · doi:10.1038/nm0695-546 · Cited by 734
Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver
Duranski, M. R., Greer, J. J. M., Dejam, A., Jaganmohan, S., Hogg, N., Langston, W., Patel, R. P., Yet, S.-F., Wang, X., Kevil, C. G., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci22493 · Cited by 674 · cited 2×
“2 nmol in murine models of myocardial infarction and hepatic IR (33).”
BackgroundSelf-citationThe emerging biology of the nitrite anion
Gladwin, M. T., Schechter, A. N., Kim-Shapiro, D. B., Patel, R. P., Hogg, N., Shiva, S., Cannon, R. O., Kelm, M., Wink, D. A., Espey, M. G., et al. (2005) · Nature Chemical Biology · doi:10.1038/nchembio1105-308 · Cited by 609 · cited 2×
“Nitrate (NO3) and nitrite (NO2), once thought to be waste products of NO metabolism, are now known to contribute substantially to NO biology by functioning as an endocrine reservoir capable of being reduced to NO within hypoxic, ischemic, or injured tissues (21, 22).”
BackgroundMethodSelf-citationShiva, S., Huang, Z., Grubina, R., Sun, J., Ringwood, L. A., MacArthur, P. H., Xu, X., Murphy, E., Darley-Usmar, V. M., & Gladwin, M. T. (2007) · Circulation Research · doi:10.1161/01.res.0000260171.52224.6b · Cited by 599 · cited 1×
“Nitrite has been identified as an important endocrine reservoir of NO activity and has been well recognized as being cytoprotective in multiple mammalian I/R models (29, 31, 33).”
BackgroundSelf-citationEffects of Dietary Nitrate on Blood Pressure in Healthy Volunteers
Larsen, F. J., Ekblom, B., Sahlin, K., Lundberg, J. O., & Weitzberg, E. (2006) · New England Journal of Medicine · doi:10.1056/nejmc062800 · Cited by 587
Shiva, S., Sack, M. N., Greer, J. J., Duranski, M., Ringwood, L. A., Burwell, L., Wang, X., MacArthur, P. H., Shoja, A., Raghavachari, N., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070198 · Cited by 555
Self-citationInhaled Nitric Oxide: A Selective Pulmonary Vasodilator: Current Uses and Therapeutic Potential
Ichinose, F., Roberts, J. D., & Zapol, W. M. (2004) · Circulation · doi:10.1161/01.cir.0000134595.80170.62 · Cited by 540
Enzymatic function of hemoglobin as a nitrite reductase that produces NO under allosteric control
Huang, Z. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24650 · Cited by 520
Millar, T. M., Stevens, C. R., Benjamin, N., Eisenthal, R., Harrison, R., & Blake, D. R. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00430-x · Cited by 491 · cited 1×
“The reduction of nitrite to NO has been shown to occur at the molybdenum location, which also happens to be the binding site for the XOR inhibitors allopurinol and oxypurinol (28).”
BackgroundInhaled Nitric Oxide Therapy in Adults
Griffiths, M. J. D., & Evans, T. W. (2005) · New England Journal of Medicine · doi:10.1056/nejmra051884 · Cited by 398 · cited 1×
“NO-based therapeutics under investigation include dietary l-arginine (9–13), drug-eluting stents (14), inhalational NO gas (15, 16), and NOS gene therapy (17, 18).”
BackgroundDiabetes-induced Coronary Vascular Dysfunction Involves Increased Arginase Activity
Romero, M. J., Platt, D. H., Tawfik, H. E., Labazi, M., El-Remessy, A. B., Bartoli, M., Caldwell, R. B., & Caldwell, R. W. (2008) · Circulation Research · doi:10.1161/circresaha.107.155028 · Cited by 386 · cited 1×
“These polyamines and arginase have been shown to increase vascular SMC hyperplasia and migration in vitro (5, 6).”
BackgroundCeruloplasmin is a NO oxidase and nitrite synthase that determines endocrine NO homeostasis
Shiva, S., Wang, X., Ringwood, L. A., Xu, X., Yuditskaya, S., Annavajjhala, V., Miyajima, H., Hogg, N., Harris, Z. L., & Gladwin, M. T. (2006) · Nature Chemical Biology · doi:10.1038/nchembio813 · Cited by 359 · cited 1×
“Furthermore, mice with diminished basal plasma nitrite concentrations are more susceptible to IR injury, an effect that is attenuated by administration of exogenous nitrite (37).”
BackgroundSelf-citationHealth Implications of Exposure to Environmental Nitrogenous Compounds
Mensinga, T. T., Speijers, G. J. A., & Meulenbelt, J. (2003) · Toxicological Reviews · doi:10.2165/00139709-200322010-00005 · Cited by 347 · cited 1×
“The two major health issues regarding nitrite toxicity concern the formation of methemoglobinemia and potential carcinogenic effects (52).”
BackgroundGladwin, M. T., Raat, N. J. H., Shiva, S., Dezfulian, C., Hogg, N., Kim-Shapiro, D. B., & Patel, R. P. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00407.2006 · Cited by 329
Self-citationInhaled nebulized nitrite is a hypoxia-sensitive NO-dependent selective pulmonary vasodilator
Hunter, C. J., Dejam, A., Blood, A. B., Shields, H., Kim-Shapiro, D. B., Machado, R. F., Tarekegn, S., Mulla, N., Hopper, A. O., Schechter, A. N., et al. (2004) · Nature Medicine · doi:10.1038/nm1109 · Cited by 281 · cited 1×
“thermore, nitrite has demonstrated the ability to mediate hypoxic pulmonary vasodilatation in a deoxyhemoglobin- and pH-dependent fashion (34).”
BackgroundSelf-citationPluta, R. M. (2005) · JAMA · doi:10.1001/jama.293.12.1477 · Cited by 261 · cited 1×
“In animal studies examining intravenous nitrite, the increase in methemoglobin remains undetectable even after prolonged nitrite delivery (53).”
BackgroundDifferential regulation of arginases and inducible nitric oxide synthase in murine macrophage cells
Morris, S. M., Kepka-Lenhart, D., & Chen, L.-C. (1998) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1998.275.5.e740 · Cited by 252
Self-citationInducible nitric oxide synthase suppresses the development of allograft arteriosclerosis.
Shears, L. L., Kawaharada, N., Tzeng, E., Billiar, T. R., Watkins, S. C., Kovesdi, I., Lizonova, A., & Pham, S. M. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119736 · Cited by 242 · cited 1×
“Others and we have previously demonstrated and we have confirmed that inducible NOS is increased within the lesion of IH (51), suggesting that this is an additional compensatory mechanism in response to an injured endothelium and decreased endothelial NOS.”
BackgroundSelf-citationl -Arginine Supplementation in Peripheral Arterial Disease: No Benefit and Possible Harm
Wilson, A. M., Harada, R., Nair, N., Balasubramanian, N., & Cooke, J. P. (2007) · Circulation · doi:10.1161/circulationaha.106.683656 · Cited by 241
Zharikov, S., Krotova, K., Hu, H., Baylis, C., Johnson, R. J., Block, E. R., & Patel, J. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00075.2008 · Cited by 239 · cited 1×
“Because uric acid has been shown to activate arginase activity in cultured endothelial cells (50), the administration of allopurinol alone might have been anticipated to have a beneficial effect.”
BackgroundMeasurement of circulating nitrite and S-nitrosothiols by reductive chemiluminescence
MacArthur, P. H., Shiva, S., & Gladwin, M. T. (2007) · Journal of Chromatography B · doi:10.1016/j.jchromb.2006.12.012 · Cited by 231 · cited 1×
“reductive chemiluminescence as described and validated previously (62, 63).”
MethodSelf-citationShears, L. L., Kibbe, M. R., Murdock, A. D., Billiar, T. R., Lizonova, A., Kovesdi, I., Watkins, S. C., & Tzeng, E. (1998) · Journal of the American College of Surgeons · doi:10.1016/s1072-7515(98)00163-x · Cited by 227 · cited 1×
“NO has been shown to have many vasoprotective properties, which has led to investigation into NO-based therapies to prevent vaso-occlusive complications of vascular injury (44, 45).”
BackgroundSelf-citationTripatara, P., Patel, N. S. A., Webb, A., Rathod, K., Lecomte, F. M. J., Mazzon, E., Cuzzocrea, S., Yaqoob, M. M., Ahluwalia, A., & Thiemermann, C. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006050450 · Cited by 226 · cited 1×
“Nitrite has been identified as an important endocrine reservoir of NO activity and has been well recognized as being cytoprotective in multiple mammalian I/R models (29, 31, 33).”
BackgroundYang, B. K., Vivas, E. X., Reiter, C. D., & Gladwin, M. T. (2003) · Free Radical Research · doi:10.1080/1071576021000033112 · Cited by 200 · cited 1×
“reductive chemiluminescence as described and validated previously (62, 63).”
MethodSelf-citationRole of the anion nitrite in ischemia-reperfusion cytoprotection and therapeutics
DEZFULIAN, C., RAAT, N., SHIVA, S., & GLADWIN, M. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.05.001 · Cited by 198
Self-citationZuckerbraun, B. S., Shiva, S., Ifedigbo, E., Mathier, M. A., Mollen, K. P., Rao, J., Bauer, P. M., Choi, J. J. W., Curtis, E., Choi, A. M. K., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.891077 · Cited by 192
Self-citationCardioprotective effects of vegetables: is nitrate the answer?
Lundberg, J. O., Feelisch, M., Björne, H., Jansson, E. Å., & Weitzberg, E. (2006) · Nitric Oxide · doi:10.1016/j.niox.2006.01.013 · Cited by 185 · cited 3×
“These doses increase plasma nitrite levels by less than 10% and are consistent with the increases observed after the ingestion of a standard leafy green salad (35) or after moderate exercise (36).”
BackgroundModerate Regular Exercise Increases Basal Production of Nitric Oxide in Elderly Women
MAEDA, S., TANABE, T., OTSUKI, T., SUGAWARA, J., IEMITSU, M., MIYAUCHI, T., KUNO, S., AJISAKA, R., & MATSUDA, M. (2004) · Hypertension Research · doi:10.1291/hypres.27.947 · Cited by 168 · cited 1×
“These doses increase plasma nitrite levels by less than 10% and are consistent with the increases observed after the ingestion of a standard leafy green salad (35) or after moderate exercise (36).”
BackgroundOral l -Arginine in Patients With Coronary Artery Disease on Medical Management
Blum, A., Hathaway, L., Mincemoyer, R., Schenke, W. H., Kirby, M., Csako, G., Waclawiw, M. A., Panza, J. A., & Cannon, R. O. (2000) · Circulation · doi:10.1161/01.cir.101.18.2160 · Cited by 162
Nitric oxide and arterial disease
Barbato, J. E., & Tzeng, E. (2004) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2004.03.043 · Cited by 162 · cited 1×
“interventions, are limited by the formation of intimal hyperplasia (IH) and restenosis (2).”
BackgroundSelf-citationTulis, D. A., Durante, W., Liu, X., Evans, A. J., Peyton, K. J., & Schafer, A. I. (2001) · Circulation · doi:10.1161/hc4701.099585 · Cited by 162
Elevated arginase I expression in rat aortic smooth muscle cells increases cell proliferation
Wei, L. H., Wu, G., Morris, S. M., & Ignarro, L. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161294898 · Cited by 144 · cited 1×
“These polyamines and arginase have been shown to increase vascular SMC hyperplasia and migration in vitro (5, 6).”
BackgroundSelf-citationTian, L., White, J. E., Lin, H.-Y., Haran, V. S., Sacco, J., Chikkappa, G., Davis, F. B., Davis, P. J., & Tsan, M.-F. (1998) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1998.275.3.c740 · Cited by 129
Walker, H. A., McGing, E., Fisher, I. B., Böger, R. H., Bode‐Böger, S. M., Jackson, G., Ritter, J. M., & Chowienczyk, P. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01380-8 · Cited by 127
The role of nitric oxide in the pathophysiology of intimal hyperplasia
Ahanchi, S. S., Tsihlis, N. D., & Kibbe, M. R. (2007) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2007.02.027 · Cited by 123 · cited 2×
“Further investigation into NO led to the discovery of multiple vasoprotective characteristics, including vasorelaxation, inhibition of endothelial cell apoptosis, inhibition of platelet aggregation and adhesion, inhibition of leukocyte chemotaxis, and inhibition of SMC proliferation and migration (3).”
BackgroundKibbe, M. R., Li, J., Nie, S., Watkins, S. C., Lizonová, A., Kovesdi, I., Simmons, R. L., Billiar, T. R., & Tzeng, E. (2000) · Journal of Vascular Surgery · doi:10.1067/mva.2000.105006 · Cited by 119
Self-citationExpression, regulation and function of carrier proteins for cationic amino acids
Closs, E. I. (2002) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200201000-00015 · Cited by 114 · cited 1×
“has similar Km values for arginine and ornithine, these amino acids can compete for cellular uptake (7).”
BackgroundNitric Oxide Inhalation During Exercise in Chronic Obstructive Pulmonary Disease
ROGER, N., BARBERÁ, J. A., ROCA, J., ROVIRA, I., GÓMEZ, F. P., & RODRIGUEZ-ROISIN, R. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.3.9611051 · Cited by 104 · cited 1×
“In addition, it is limited by systemic toxicity, as hemodynamic instability can occur when its use is interrupted (19, 20).”
BackgroundTzeng, E., Shears, L. L., Robbins, P. D., Pitt, B. R., Geller, D. A., Watkins, S. C., Simmons, R. L., & Billiar, T. R. (1996) · Molecular Medicine · doi:10.1007/bf03401618 · Cited by 102 · cited 1×
“branes (Schleicher & Schuell) as described previously (59).”
BackgroundSelf-citationRaat, N. J. H., Noguchi, A. C., Liu, V. B., Raghavachari, N., Liu, D., Xu, X., Shiva, S., Munson, P. J., & Gladwin, M. T. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.05.015 · Cited by 97
Cell cycle effects of nitric oxide on vascular smooth muscle cells
Sarkar, R., Gordon, D., Stanley, J. C., & Webb, R. C. (1997) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1997.272.4.h1810 · Cited by 87 · cited 1×
“These findings are consistent with the effects of NO donors or NOS enzyme overexpression in SMCs (39).”
ResultZuckerbraun, B. S., Stoyanovsky, D. A., Sengupta, R., Shapiro, R. A., Ozanich, B. A., Rao, J., Barbato, J. E., & Tzeng, E. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00592.2005 · Cited by 80
Self-citationL-Arginine therapy in cardiovascular pathologies: beneficial or dangerous?
Böger, R. H. (2008) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e3282f2b0c3 · Cited by 77
Bauer, P. M., Buga, G. M., & Ignarro, L. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211443198 · Cited by 66
Arginase Promotes Neointima Formation in Rat Injured Carotid Arteries
Peyton, K. J., Ensenat, D., Azam, M. A., Keswani, A. N., Kannan, S., Liu, X.-M., Wang, H., Tulis, D. A., & Durante, W. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.183392 · Cited by 64 · cited 2×
“Furthermore, it has been shown that increased arginase expression promotes neointima formation within injured vessels (8).”
BackgroundEvolving Modalities for Femoropopliteal Interventions
Ansel, G. M., & Lumsden, A. B. (2009) · Journal of Endovascular Therapy · doi:10.1583/08-2654.1 · Cited by 54 · cited 1×
“NO-based therapeutics under investigation include dietary l-arginine (9–13), drug-eluting stents (14), inhalational NO gas (15, 16), and NOS gene therapy (17, 18).”
BackgroundThe mediterranean diet: Rationale and evidence for its benefit
de Lorgeril, M., & Salen, P. (2008) · Current Atherosclerosis Reports · doi:10.1007/s11883-008-0080-5 · Cited by 50
Zuckerbraun, B. S., Shapiro, R. A., Billiar, T. R., & Tzeng, E. (2003) · Circulation · doi:10.1161/01.cir.0000081947.00070.07 · Cited by 49 · cited 1×
“(1:20,000; Pierce) as previously described (60).”
Self-citationWardle, R. L., Strauss, J. D., Rembold, C. M., & Murphy, R. A. (1997) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1997.272.6.c1810 · Cited by 34
Granada, J. F., Ensenat, D., Keswani, A. N., Kałuża, G. L., Raizner, A. E., Liu, X., Peyton, K. J., Azam, M. A., Wang, H., & Durante, W. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000184779.01822.9d · Cited by 25
Inhaled nitric oxide and exercise capacity in congestive heart failure
Matsumoto, A., Momomura, S., Hirata, Y., Aoyagi, T., Sugiura, S., & Omata, M. (1997) · The Lancet · doi:10.1016/s0140-6736(05)62897-8 · Cited by 23 · cited 1×
“In addition, it is limited by systemic toxicity, as hemodynamic instability can occur when its use is interrupted (19, 20).”
BackgroundDudek, D., Legutko, J., Heba, G., Bartuś, S., Partyka, Ł., Huk, I., Dembinska-Kiec, A., Kałuża, G. L., & Dubiel, J. S. (2004) · American Heart Journal · doi:10.1016/j.ahj.2003.10.025 · Cited by 17
Nitric oxide synthase gene therapy in vascular pathology
Kibbe, M. R., & Tzeng, E. (2000) · Seminars in Perinatology · doi:10.1016/s0146-0005(00)80056-7 · Cited by 16 · cited 1×
“NO-based therapeutics under investigation include dietary l-arginine (9–13), drug-eluting stents (14), inhalational NO gas (15, 16), and NOS gene therapy (17, 18).”
BackgroundSelf-citationThe Emerging Role of Gene Therapy in the Treatment of Cardiovascular Diseases
Barbato, J. E., Kibbe, M. R., & Tzeng, E. (2003) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360390250621 · Cited by 14 · cited 1×
“NO-based therapeutics under investigation include dietary l-arginine (9–13), drug-eluting stents (14), inhalational NO gas (15, 16), and NOS gene therapy (17, 18).”
BackgroundSelf-citation
Cited by
Nitrate and periplasmic nitrate reductases
Sparacino-Watkins, C., Stolz, J. F., & Basu, P. (2014) · Chem. Soc. Rev. · doi:10.1039/c3cs60249d · Cited by 426
Maia, L. B., & Moura, J. J. G. (2014) · Chemical Reviews · doi:10.1021/cr400518y · Cited by 401
Lidder, S., & Webb, A. J. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04420.x · Cited by 360
Kapil, V., Khambata, R. S., Jones, D. A., Rathod, K., Primus, C., Massimo, G., Fukuto, J. M., & Ahluwalia, A. (2020) · Pharmacological Reviews · doi:10.1124/pr.120.019240 · Cited by 248
“In addition, the authors demonstrated that this beneficial effect of nitrite was attenuated if rats were pretreated allopurinol, implicating XOR as the nitrite reductase in this setting (Alef et al., 2011).”
BackgroundContribution of uric acid to cancer risk, recurrence, and mortality
Fini, M. A., Elias, A., Johnson, R. J., & Wright, R. M. (2012) · Clinical and Translational Medicine · doi:10.1186/2001-1326-1-16 · Cited by 240
“Confounding problems associated with chronic inhibition of XOR include diarrhea, diminished renal function, leukopenia, hypersensitivity reactions, vasculitis [3], and even exacerbation of vascular injury through recently identified effects on nitrite reduction [153].”
Background
Metadata
- Authors
- Alef, M. J., Vallabhaneni, R., Carchman, E., Morris, S. M., Shiva, S., Wang, Y., Kelley, E. E., Tarpey, M. M., Gladwin, M. T., Tzeng, E., & Zuckerbraun, B. S.
- Affiliations
- University of Pittsburgh (US)
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2011-04-01
- Volume
- 121
- Issue
- 4
- Pages
- 1646-1656
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3069768
- OpenAlex
- W2082664405
- Cited by
- 101
- References
- 64
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 6 · 2023: 3 · 2022: 3 · 2021: 5 · 2020: 3 · 2019: 5 · 2018: 5 · 2017: 4 · 2016: 8 · 2015: 12 · 2014: 9 · 2013: 12 · 2012: 14
- FWCI
- 9.60
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Heart Association
- Hemophilia Center of Western Pennsylvania
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01HL096973, R01HL098032)
- National Institute of General Medical Sciences (R01GM57384, R01GM057384)
- National Institute of Diabetes and Digestive and Kidney Diseases (RC1DK085852)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Keywords
- nitrite, nitric oxide, intimal hyperplasia, vascular injury, arginase-1, xanthine oxidoreductase, smooth muscle cell proliferation, p21, endothelial dysfunction, vascular protection, nitrite supplementation
- MeSH terms
- Animals, Arginase, Arginine, Hyperplasia, Male, Nitric Oxide, Sodium Nitrite, Xanthine Dehydrogenase, Signal Transduction, Rats, Sprague-Dawley, Tunica Intima, Myocytes, Smooth Muscle, Cell Proliferation, Cyclin-Dependent Kinase Inhibitor p21, Rats, Nitric Oxide Synthase Type III
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.